Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPH, Detemir, and Glargine in Type 1 Diabetes
NCT01461616Phase 3Completed
- Sponsor
- Aarhus University
- Start
- Feb 2012
- Primary completion
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin detemir, insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Aarhus University. Started Feb 2012; status: completed.
02
Drugs
insulin detemirinsulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01461616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01461616.